The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed) |
93.350 |
RFA-TR-21-015 |
| Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) |
93.279 |
RFA-DA-22-002 |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-012 |
| DoD Peer Reviewed Orthopaedic, Clinical Trial Award |
12.420 |
W81XWH-21-PRORP-CTA |
| DoD Peer Reviewed Orthopaedic, Clinical Translational Research Award |
12.420 |
W81XWH-21-PRORP-CTRA |
| Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) |
93.173 |
PAR-21-185 |
| Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) |
93.859 |
PAR-21-196 |
| Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) |
93.242 |
PAR-21-211 |
| Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) |
93.242 |
PAR-21-210 |
| Research on Autism Spectrum Disorders (R03 Clinical Trial Optional) |
93.113, 93.173, 93.242, 93.865 |
PA-21-199 |
| Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) |
93.113, 93.173, 93.242, 93.853, 93.865 |
PA-21-200 |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) |
93.121, 93.313, 93.846, 93.855 |
RFA-AR-21-015 |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) |
93.121, 93.313, 93.846, 93.855 |
RFA-AR-21-016 |
| Research on Autism Spectrum Disorders (R01 Clinical Trial Optional) |
93.113, 93.173, 93.242, 93.853, 93.865 |
PA-21-201 |
| Technologies to Advance Precision Medicine for Reproductive Health and Infertility (R43, R44 Clinical Trial Optional) |
93.865 |
RFA-HD-22-010 |
| NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) |
93.173 |
PAR-21-187 |
| Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-012 |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) |
93.172 |
RFA-HG-21-008 |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) |
93.172 |
RFA-HG-21-006 |
| Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
PAR-21-162 |
| Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) |
93.242, 93.279, 93.855 |
RFA-AI-21-024 |
| Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional) |
93.242, 93.279, 93.855 |
RFA-AI-21-025 |
| Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-009 |
| Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional) |
93.242, 93.279, 93.855 |
RFA-AI-21-023 |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) |
93.172 |
RFA-HG-21-007 |
| Nutrition Obesity Research Centers (P30 Clinical Trial Optional) |
93.847 |
RFA-DK-21-015 |
| User-Based Design to Aid in Contraceptive Development by Small Business (R43 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-22-019 |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional) |
93.113, 93.313, 93.399, 93.866, 93.989 |
RFA-TW-21-001 |
| Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
93.279 |
PAR-21-208 |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional) |
93.113, 93.313, 93.399, 93.866, 93.989 |
RFA-TW-21-002 |
| Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed) |
93.310 |
RFA-RM-21-021 |
| Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed) |
93.310 |
RFA-RM-21-022 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) |
93.121, 93.394, 93.395 |
PAR-21-166 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) |
93.394, 93.395 |
PAR-21-206 |
| NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed) |
93.855, 93.879 |
RFA-LM-21-001 |
| NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) |
93.172 |
PAR-21-143 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
93.394, 93.395 |
RFA-CA-21-036 |
| Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867 |
RFA-MD-21-004 |
| Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional) |
93.213, 93.853 |
RFA-AT-21-006 |
| Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) |
93.866 |
PAR-21-212 |
Search Results 2201-2240 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
